Clinical trial
Overtaking Intra and Inter Tumoral Heterogeneity In Von Hippel-Lindau Related Renal Cancer
NCT06195150 is registered in ClinicalTrials.gov with IRCCS San Raffaele as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Overtaking Intra and Inter Tumoral Heterogeneity In Von Hippel-Lindau Related Renal Cancer
- Lead sponsor
- IRCCS San Raffaele
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- November 8, 2023
- Completion date
- May 19, 2026
- Enrollment
- 3 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
clear cell renal cell carcinoma, vhl syndrome